BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9396326)

  • 1. [Changes in serum anti-Helicobacter pylori IgG antibody, pepsinogen I, and pepsinogen II after eradication therapy of Helicobacter pylori].
    Ando H; Kagaya T; Takemori Y; Noda Y
    Nihon Shokakibyo Gakkai Zasshi; 1997 Nov; 94(11):723-9. PubMed ID: 9396326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in serum anti-Helicobacter pylori IgG antibody, pepsinogen I, pepsinogen II after eradication therapy of Helicobacter pylori].
    Matuskawa Y
    Nihon Shokakibyo Gakkai Zasshi; 1998 May; 95(5):460. PubMed ID: 9621705
    [No Abstract]   [Full Text] [Related]  

  • 3. The clinical usefulness of serum pepsinogens, specific IgG anti-HP antibodies and gastrin for monitoring Helicobacter pylori treatment in older people.
    Pilotto A; Franceschi M; Leandro G; DiMario F; Soffiati G; Scagnelli M; Bozzola L; Fabrello R; Valerio G
    J Am Geriatr Soc; 1996 Jun; 44(6):665-70. PubMed ID: 8642157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of factors associated with recovery of the serum pepsinogen ratio after
    Cho JH; Jeon SR; Jin SY; Park S
    Scand J Gastroenterol; 2019 Nov; 54(11):1306-1314. PubMed ID: 31702966
    [No Abstract]   [Full Text] [Related]  

  • 5. [Erosive duodenitis after eradication therapy for Helicobacter pylori].
    Goto T; Hisiki S; Tanaka M; Siwa T; Tochikubo O; Kawaguchi Y; Yokoyama N; Komatu K; Suzuki R
    Nihon Shokakibyo Gakkai Zasshi; 1999 Jan; 96(1):14-20. PubMed ID: 10047687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in serum pepsinogen, gastrin, and immunoglobulin G antibody titers in helicobacter pylori-positive gastric ulcer after eradication of infection.
    Ohkusa T; Takashimizu I; Fujiki K; Araki A; Honda K; Shimoi K; Sakurazawa T; Horiuchi T; Suzuki S; Ariake K; Ishii K
    J Clin Gastroenterol; 1997 Jul; 25(1):317-22. PubMed ID: 9412911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting Helicobacter pylori eradication using a seven-day triple therapy with a proton pump inhibitor, tinidazole and clarithromycin, in Brazilian patients with peptic ulcer.
    Silva FM; Zaterka S; Eisig JN; Chehter EZ; Chinzon D; Laudanna AA
    Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(1):11-6. PubMed ID: 11378678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure.
    Mak SK; Loo CK; Wong PN; Lo KY; Tong GM; Lam EK; Wong AK
    Singapore Med J; 2003 Feb; 44(2):74-8. PubMed ID: 14503780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease--A pilot study.
    Lüth S; Teyssen S; Kölbel CB; Singer MV
    Z Gastroenterol; 2001 Apr; 39(4):279-81, 284-5. PubMed ID: 11367976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percentage changes in serum pepsinogens are useful as indices of eradication of Helicobacter pylori.
    Furuta T; Kaneko E; Baba S; Arai H; Futami H
    Am J Gastroenterol; 1997 Jan; 92(1):84-8. PubMed ID: 8995943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up study of serum immunoglobulin G and immunoglobulin A antibodies after Helicobacter pylori eradication.
    Kato S; Furuyama N; Ozawa K; Ohnuma K; Iinuma K
    Pediatrics; 1999 Aug; 104(2):e22. PubMed ID: 10429140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetracycline, metronidazole and amoxicillin-metronidazole combinations in proton pump inhibitor-based triple therapies are equally effective as alternative therapies against Helicobacter pylori infection.
    Matsushima M; Suzuki T; Kurumada T; Watanabe S; Watanabe K; Kobayashi K; Deguchi R; Masui A; Takagi A; Shirai T; Muraoka H; Kobayashi I; Mine T
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):232-6. PubMed ID: 16460479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum pepsinogens as an early diagnostic marker of H. pylori eradication.
    Shirai N; Furuta T; Sugimoto M; Kanaoka S; Watanabe F; Takashima M; Yamada M; Futami H; Sato Y; Kubota H; Kodaira M; Kajimura M; Maekawa M; Hishida A
    Hepatogastroenterology; 2008; 55(82-83):486-90. PubMed ID: 18613393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients.
    Pilotto A; Franceschi M; Leandro G; Bozzola L; Fortunato A; Rassu M; Meli S; Soffiati G; Scagnelli M; Di Mario F; Valerio G
    J Gastroenterol Hepatol; 1999 May; 14(5):468-75. PubMed ID: 10355512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
    Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease.
    Liou JM; Chen CY; Wu MS; Hsu MT; Fang CC; Lin YL; Chang MC; Lin JT; Wang HP
    Hepatogastroenterology; 2006; 53(71):792-6. PubMed ID: 17086891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori.
    Sieg A; Sellinger M; Schlauch D; Hörner M; Fuchs W
    Aliment Pharmacol Ther; 1999 Jul; 13(7):865-8. PubMed ID: 10383519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard triple therapy in Helicobacter pylori eradication in Turkey: Systematic evaluation and meta-analysis of 10-year studies.
    Sezgin O; Aydın MK; Özdemir AA; Kanık AE
    Turk J Gastroenterol; 2019 May; 30(5):420-435. PubMed ID: 31060997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.